HCM
Highline Capital Management Portfolio holdings
AUM
$51.6M
This Quarter Return
+6.08%
1 Year Return
-21.56%
3 Year Return
+183.68%
5 Year Return
+227.52%
10 Year Return
–
AUM
$1.29B
AUM Growth
+$1.29B
(-12%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-16.95%
Top 10 Holdings %
Top 10 Hldgs %
57.2%
Holding
46
New
10
Increased
4
Reduced
14
Closed
14
Top Buys
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$111M |
| 2 |
ArcelorMittal
MT
|
$56.1M |
| 3 |
SAFM
Sanderson Farms Inc
SAFM
|
$52.4M |
| 4 |
Tyson Foods
TSN
|
$52.2M |
| 5 |
Sysco
SYY
|
$43.7M |
Top Sells
| 1 |
BERY
Berry Global Group, Inc.
BERY
|
$92.6M |
| 2 |
Royal Caribbean
RCL
|
$60.4M |
| 3 |
Rio Tinto
RIO
|
$57.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
$52M |
| 5 |
Moelis & Co
MC
|
$45.2M |
Sector Composition
| 1 | Healthcare | 35.67% |
| 2 | Consumer Discretionary | 23.34% |
| 3 | Consumer Staples | 11.53% |
| 4 | Materials | 10.51% |
| 5 | Technology | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
1
DELISTED
CATALENT, INC.
CTLT
| $111M | 8.16% | +2,056,709 | New | +$111M |
|
2
IQVIA
IQV
$32.4B
| $90.2M | 6.6% | 560,826 -192,770 | -26% | -$31M |
|
3
Commercial Metals
CMC
$6.46B
| $79.1M | 5.79% | 4,434,008 +395,000 | +10% | +$7.05M |
|
|
GRA
4
DELISTED
W.R. Grace & Co.
GRA
| $74.1M | 5.43% | 974,080 +37,680 | +4% | +$2.87M |
|
5
Caesars Entertainment
CZR
$5.57B
| $71.1M | 5.2% | 1,542,845 -80,900 | -5% | -$3.73M |
|
6
Elevance Health
ELV
$71.8B
| $69.4M | 5.08% | 246,000 -32,858 | -12% | -$9.27M |
|
|
7
Royal Caribbean
RCL
$98.7B
| $67.5M | 4.94% | 557,250 -498,000 | -47% | -$60.4M |
|
8
Take-Two Interactive
TTWO
$43B
| $64.4M | 4.71% | 567,100 -79,000 | -12% | -$8.97M |
|
|
9
ArcelorMittal
MT
$25.4B
| $56.1M | 4.11% | +3,112,400 | New | +$56.1M |
|
|
SAFM
10
DELISTED
Sanderson Farms Inc
SAFM
| $52.4M | 3.84% | +383,945 | New | +$52.4M |
|
|
11
Tyson Foods
TSN
$20.2B
| $52.2M | 3.82% | +646,100 | New | +$52.2M |
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $52M | 3.8% | 607,021 -459,228 | -43% | -$39.3M |
|
13
Marvell Technology
MRVL
$54.2B
| $49.7M | 3.64% | 2,083,400 -538,000 | -21% | -$12.8M |
|
14
Boyd Gaming
BYD
$6.88B
| $48M | 3.51% | 1,781,139 -400,800 | -18% | -$10.8M |
|
15
VICI Properties
VICI
$36B
| $46.3M | 3.39% | 2,098,660 -25,000 | -1% | -$551K |
|
|
16
Sysco
SYY
$38.5B
| $43.7M | 3.2% | +618,500 | New | +$43.7M |
|
|
MTOR
17
DELISTED
MERITOR, Inc.
MTOR
| $39.6M | 2.9% | 1,633,980 -271,800 | -14% | -$6.59M |
|
18
UroGen Pharma
URGN
$900M
| $36.4M | 2.67% | 1,014,078 +27,200 | +3% | +$978K |
|
19
Pegasystems
PEGA
$9.27B
| $35.8M | 2.62% | 503,288 -150,000 | -23% | -$10.7M |
|
20
Align Technology
ALGN
$10.3B
| $27.5M | 2.01% | +100,500 | New | +$27.5M |
|
21
Ultragenyx Pharmaceutical
RARE
$2.89B
| $24.8M | 1.81% | 390,453 -219,610 | -36% | -$13.9M |
|
|
GLUU
22
DELISTED
Glu Mobile Inc.
GLUU
| $22.3M | 1.63% | +3,102,500 | New | +$22.3M |
|
|
FPAC.U
23
DELISTED
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
| $22.2M | 1.62% | 2,076,099 | – | – |
|
24
Amicus Therapeutics
FOLD
$2.34B
| $18.9M | 1.38% | +1,511,000 | New | +$18.9M |
|
25
Alector
ALEC
$238M
| $12.3M | 0.9% | 645,782 -174,508 | -21% | -$3.32M |
|